SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-039503
Filing Date
2021-10-06
Accepted
2021-10-06 19:00:57
Documents
2
Period of Report
2021-10-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1517
2 EX-24 DOCUMENT attachment1.htm EX-24 2353
  Complete submission text file 0000899243-21-039503.txt   5203
Mailing Address 245 MAIN STREET CAMBRIDGE MA 02142
Business Address 245 MAIN STREET CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Issuer) CIK: 0001745020 (see all company filings)

IRS No.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 600 MONTGOMERY STREET SUITE 4500 SAN FRANCISCO CA 94111
Business Address
Rome Michael E (Reporting) CIK: 0001820818 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40869 | Film No.: 211310694